Contact us
JLL | Life sciences portfolio optimization

Unlock capital from real estate

Don't let valuable capital remain trapped in underperforming real estate.

Let's talk

Proven portfolio results

dollar
Optimised spend across client portfolios
$193M
Maximised real estate portfolio value with comprehensive advisory spanning lease restructuring and space rationalisation
strategic management
Portfolio under strategic management
5.9M sq m
Managed by our Occupancy Planning team, delivering portfolio optimisation strategies that identify quick wins and develop clear long-term portfolio strategies aligned with business objectives.
M&A portfolio optimization
M&A portfolio optimisation
$85M
Total cost benefits and avoidance delivered through comprehensive portfolio analysis during healthtech M&A partnership, optimising real estate footprint and operational efficiencies across the transaction lifecycle

How we've helped large pharma businesses

  • How we’ve helped large pharma businesses

    Global portfolio cost savings

    A global pharmaceutical company, in the process of acquiring an international drug company, partnered with JLL to create a comprehensive portfolio consolidation and integration plan. This plan - encompassing 55 international markets, 160+ properties and $330M in annual occupancy costs – identified optimal locations while achieving $54M to $83M in potential annual cost savings.​

  • Strategic campus development

    A global pharma company wanted a cutting-edge research campus to boost innovation. JLL helped create a 535K-square- foot facility in Southern California with state-of-the-art R&D labs. By planning ahead, we ensured the campus could expand an additional 100K square feet, allowing the flexibility to adapt to new research opportunities and gain a competitive edge.​

Transform your real estate from a capital drain into a strategic asset through:

Lease restructuring & renegotiation

Expert negotiation to restructure existing leases, reduce occupancy costs and free up capital trapped by unfavourable lease terms.

Lease portfolio assessment & strategy

Comprehensive evaluation of your leasing portfolio to uncover opportunities to reduce costs, optimise capital and improve operations.

Sale & leaseback advisory

Strategic guidance on sale-leaseback opportunities to unlock capital from owned assets while securing favorable long-term leases.

Portfolio consolidation & optimisation

Strategic lease advisory for portfolio consolidation, space reduction and operational efficiency improvements across global portfolios.

Convert lease obligations into ownership opportunities

Discover how portfolio optimization frees up resources for your next breakthrough by strategically consolidating facilities, transitioning owned assets to flexible leases or rightsizing your footprint to maximize R&D investment.

PRIVACY NOTICE

Jones Lang LaSalle (JLL), together with its subsidiaries and affiliates, is a leading global provider of real estate and investment management services. We take our responsibility to protect the personal information provided to us seriously.

Generally the personal information we collect from you are for the purposes of dealing with your enquiry.

We endeavor to keep your personal information secure with appropriate level of security and keep for as long as we need it for legitimate business or legal reasons. We will then delete it safely and securely. For more information about how JLL processes your personal data, please view our privacy statement.

Thank you

Thank you for submitting your life sciences enquiry. We will be in touch with you within the next three business days.